Fundraising Fox

Pini Orbach

Investor

Managing Partner at Arkin Capital

Tel Mond, Center District, Israel

About

Dr. Pini Orbach joined Arkin in 2010 and serves as a Managing Partner overseeing Arkin Bio Ventures and Arkin Bio Capital Funds. He has over 20 years of experience as a drug developer and investor, having incubated and backed multiple biopharmaceutical companies. Previously he was CEO of Optimata Ltd. and CytoD and worked at U.S. firms including Arisaph Pharmaceuticals and Epix Pharmaceuticals; he holds a Ph.D. in Physiology and Functional Genomics from the University of Florida and completed a postdoctoral fellowship at Harvard Medical School.

LinkedIn ↗

Invests in

Biotech

Experience

  1. Arkin CapitalHead of Pharma & Managing Partnercurrent2010 — present
  2. NanoDocCEO2010 — 2011
  3. Optimata Ltd.CEO2009 — 2010
  4. CytoDCEO2008 — 2009
  5. Epix PharmaceuticalsDirector and Product Leader2004 — 2006

Education

  1. University of Florida College of MedicinePhD, cardiovascular1996 — 1999

Same school

Also attended University of Florida College of Medicine1

Kinam HongPartner at Sofinnova Partners

Shared employers

Also worked at Epix Pharmaceuticals2

Stephen KnightPresident & Senior Managing Partner at F-Prime Capital PartnersSharon ShachamManaging Partner at E44 Ventures

Investments

Investor

BiosightcCAM BiotherapeuticsCense PharmaceuticalsHuman Immunology Biosciences (HiBio)Keros Therapeutics (KROS)Redpin TherapeuticsUroGen Pharma (URGN)

Per the firm's website.

Colleagues at Arkin Capital

Adar Makovski Silverstein
Principal at Arkin Capital
Alon Lazarus
Managing Partner at Arkin Capital
Avital Adler
Principal at Arkin Capital
Benzion Amoyav
Investment Analyst at Arkin Capital
Chen Koton
Direct Equity at Arkin Capital
Dana Azulay
Bookkeeper at Arkin Capital
Danny Kleinhendler
Legal Counsel at Arkin Capital
David Alterman
Principal at Arkin Capital